0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Health regulators in the United States on Monday approved ImmunityBio’s combination therapy for the treatment of a type of bladder cancer. This ends the company's struggles to bring the drug to the market.
Share this article
If you liked this article share it with your friends.they will thank you later
/medriva/media/media_files/gFP9wicR0oa3mNMm2YSj.jpg)
2 Min read
/medriva/media/post_banners/content/uploads/2024/02/mark-cuban-cost-plus-drug-company-mcdpdc-study-in-urology-practice-20240222015640.jpg)
/medriva/media/post_banners/content/uploads/2024/02/urethral-strictures-in-men-using-intermittent-catheterization-20240222012648.jpg)
/medriva/media/post_banners/content/uploads/2024/02/stress-urinary-incontinence-surgical-options-20240221175621.jpg)
/medriva/media/post_banners/content/uploads/2024/02/new-england-bladder-cancer-study-nebcs-20240217031327.jpg)
/medriva/media/post_banners/content/uploads/2024/02/oxidative-stress-and-ros-induced-inflammation-in-icbps-20240208011414.jpg)
/medriva/media/post_banners/content/uploads/2024/02/bladder-training-for-frequent-urination-20240203214344.jpg)
/medriva/media/post_banners/content/uploads/2024/02/cloudy-urine-causes-and-treatment-20240203154315.jpg)
/medriva/media/post_banners/content/uploads/2024/02/differential-gene-co-expression-analysis-for-bladder-cancer-20240202174342.jpg)
/medriva/media/post_banners/content/uploads/2024/02/open-image-dataset-of-urinary-cells-for-infection-marker-identification-20240201161327.jpg)
/medriva/media/agency_attachments/PAJ1yimoQnd9vBc8FTrz.png)
/medriva/media/media_files/JW1Y2Cm26JYNPS4FZ4Gq.png)